GSK3B and Alzheimer disease: Abnormal regulation of GSK-3β has been linked to both the onset and progression of different chronic conditions such as diabetes, cancer, neurodegenerative (e.g., AD, PD, ALS), and behavioral diseases (e.g., bipolar disorder (BD), major depression (MD), schizophrenia).